Tailored drug combinations improve outcomes for treatment-resistant advanced melanoma
A new study led by researchers at The University of Texas MD Anderson Cancer Center has identified a way to tailor drug combinations based on specific…
Researchers uncover possible cause of pain in neurofibromatosis type 1
Researchers at Cincinnati Children’s have identified a potential new way to relieve chronic pain linked to neurofibromatosis type…